On 13 November 2025, the UK Industry Pharmacogenomics Network (UK-IPN) attended the 4th National Pharmacogenomics (PGx) and Medicines Optimisation Network of Excellence event, hosted by the North West Genomic Medicine Service Alliance in Manchester.
Medicines Safety Week, launched by the UK Government, underscores the importance of reducing medication-related harm. At the UK Industry Pharmacogenomics Network (UK-IPN), we believe this initiative as a catalyst for integrating pharmacogenomics into clinical practice.
NHS England's Medium Term Planning Framework (2026–2029) places genomics at the heart of service delivery. From April 2026, all NHS providers are expected to deliver services in line with the NHS Genomic Medicine Service (GMS) specification. This includes genomic testing and clinical functions for cancer, rare disease, and population health.
The UK Industry Pharmacogenomics Network are excited to announce the launch of new website. The UK Industry Pharmacogenomics Network (UK-IPN), formed in 2024 is a pioneering collaborative of Medical Device Manufacturers with an interest in Pharmacogenomics. Our purpose - to support and empower the life science industry in advancing pharmacogenomic...
